| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 66.95B | 61.27B | 67.54B | 65.02B | 58.06B | 45.82B |
| Gross Profit | 15.63B | 9.59B | 16.40B | 16.37B | 13.16B | 8.47B |
| EBITDA | 26.71B | 19.34B | 27.89B | 28.68B | 25.40B | 19.47B |
| Net Income | 4.80B | 4.31B | 2.81B | 5.19B | 6.44B | 3.28B |
Balance Sheet | ||||||
| Total Assets | 279.92B | 292.82B | 293.28B | 276.46B | 274.95B | 237.57B |
| Cash, Cash Equivalents and Short-Term Investments | 56.08B | 55.27B | 48.22B | 38.31B | 27.57B | 23.66B |
| Total Debt | 151.29B | 156.26B | 165.70B | 167.38B | 181.19B | 173.73B |
| Total Liabilities | 186.56B | 195.10B | 202.06B | 195.04B | 206.51B | 190.19B |
| Stockholders Equity | 48.72B | 53.30B | 47.76B | 42.77B | 35.33B | 23.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.98B | 20.93B | 18.13B | -2.02B | -17.87B |
| Operating Cash Flow | 0.00 | 19.62B | 30.20B | 27.95B | 26.38B | 19.90B |
| Investing Cash Flow | 0.00 | -7.28B | -6.75B | 8.49B | -18.42B | -31.48B |
| Financing Cash Flow | 0.00 | -2.20B | -13.51B | -24.60B | -5.46B | 12.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥87.27B | 60.23 | ― | 3.48% | 1.42% | 32.92% | |
70 Outperform | ¥144.51B | 10.77 | ― | 3.65% | 3.06% | 1.48% | |
70 Outperform | ¥14.29B | 9.45 | ― | 3.85% | 8.49% | 32.73% | |
67 Neutral | ¥70.88B | 11.67 | ― | 3.63% | 0.60% | 10.27% | |
65 Neutral | ¥13.46B | 9.42 | ― | 3.04% | 3.34% | 11.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥38.89B | 10.63 | ― | 0.79% | -9.29% | 52.91% |